Dr. Mylene Ongos Hilo

DMD | Dentist



  
  5214 N Western Ave, Suite 303, Chicago
  Illinois, 60625-2589

  773-907-1878    773-907-1870 Maps & Directions
Dr. Mylene Ongos Hilo is a Chicago, Illinois based Dentist who is specialized in General Practice Dentistry. She does not accept the Medicare-approved amount. Patients will be billed for the treatment. Her current practice location is 5214 N Western Ave, Suite 303, Chicago. Patients can reach her at 773-907-1878.
Dr. Mylene Ongos Hilo is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Mylene Ongos Hilo speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Mylene Ongos Hilo
Specialization: Dentist
Gender:Female
Credentials: DMD
Accepts Medicare Assignment:No
Practice Address:5214 N Western Ave, Suite 303, Chicago,
Illinois, 60625-2589
Phone:773-907-1878
Fax:773-907-1870
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1437201134
NPI Enumeration Date: 16 Jan, 2007
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 5214 N Western Ave, Suite 303
Chicago, Illinois
Zip: 60625-2589
Phone Number: 773-907-1878
Fax Number: 773-907-1870
Patients can reach Dr. Mylene Ongos Hilo at 5214 N Western Ave, Suite 303, Chicago, Illinois or can call to book an appointment on 773-907-1878. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: